Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v2.3.0.15
Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Grant revenue $ 255,632 $ 149,588 $ 597,729 $ 149,588
Operating expenses:        
Research and development 3,858,141 2,480,984 8,159,992 6,508,363
Selling, general and administrative 2,870,603 1,287,177 7,499,454 3,233,414
Total operating expenses 6,728,744 3,768,161 15,659,446 9,741,777
Loss from operations (6,473,112) (3,618,573) (15,061,717) (9,592,189)
Other income (expense):        
Interest income 7,362 2,398 13,865 6,159
Interest expense (564) (832) (3,229) (553,821)
Change in derivative liabilities 7,208 (87,753) (956,933) (671,360)
Loss on extinguishment of debt       (41,717,380)
Other (709) (90) (1,807) (2,668)
Total other income (expense), net 13,297 (86,277) (948,104) (42,939,070)
Loss before income taxes (6,459,815) (3,704,850) (16,009,821) (52,531,259)
Benefit from income tax 6,403,928   6,403,928  
Loss from continuing operations (55,887) (3,704,850) (9,605,893) (52,531,259)
Discontinued operations, net of tax effect:        
Gain on sale 20,108,502   19,498,798  
(Loss) income from operations (220,682) 1,323,191 3,328,009 4,619,627
Net income (loss) 19,831,933 (2,381,659) 13,220,914 (47,911,632)
Preferred stock dividends (25,000) (25,000) (75,000) (8,181,745)
Income (loss) attributable to common stockholders $ 19,806,933 $ (2,406,659) $ 13,145,914 $ (56,093,377)
Income (loss) per common share (basic and diluted):        
Continuing operations   $ (0.05) $ (0.11) $ (0.76)
Discontinued operations $ 0.21 $ 0.02 $ 0.26 $ 0.06
Attributable to common stockholders $ 0.21 $ (0.03) $ 0.15 $ (0.70)
Weighted average shares outstanding:        
Basic and diluted 93,070,235 80,605,072 89,410,150 80,149,302